Patient with poor responder ovareis. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: Since the 3rd day of menses will begin GnRH agonist buserelin acetate (Cinafact,cinagen,Iran) at a dose of 50 µg subcutaneously twice daily and menotropin(BSV,Ger
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Patient with poor responder ovaries Age 18 years
Exclusion criteria
Exclusion criteria: Sever Endomtriosis Sever Male Factor Uncontrol Endocrine Disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: 5 Week after embryo transfer. Method of measurement: Vaginal Sonography to see fetus in gestational sac. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Check BHCG.;Fetus number. Timepoint: 2-3 day after follicle aspiration. Method of measurement: Fetus in labratory.;Oocyte number. Timepoint: In follicular aspiration day. Method of measurement: To see oocytes in labratory.;The number of dominant follicle. Timepoint: In ovulation stimulation cycle. Method of measurement: Vaginal sonography.;Estradiol level in blood. Timepoint: To see 2-3number of >=17 mm follicle. Method of measurement: Check in labratoty.;Gonadotropin dosage. Timepoint: At the end of ovarian stimulation. Method of measurement: International Units. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Lida Saeed
Yazd University of Medical Sciences
Outcome results
None listed